Common heart medications
Pro Research Analysisby 
Searched over 200M research papers
Common Heart Medications: An Overview
Heart medications play a crucial role in managing various cardiovascular conditions, including coronary heart disease (CHD), heart failure, and hypertension. This article provides an overview of the most commonly prescribed heart medications, their uses, and their potential side effects.
Beta-Blockers: Essential for Heart Failure and CHD
Beta-blockers are widely used in the treatment of heart failure and coronary heart disease. They work by blocking the effects of adrenaline on the heart, which helps to reduce heart rate and blood pressure, thereby decreasing the heart's workload. Studies have shown that beta-blockers are effective in reducing morbidity and mortality in patients with heart failure with reduced ejection fraction2 9. Additionally, beta-blockers are commonly prescribed for secondary prevention in CHD patients, with a prevalence of 73.4% in South America1.
ACE Inhibitors and ARBs: Key Players in Heart Failure Management
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are crucial in managing heart failure and hypertension. These medications help relax blood vessels, lower blood pressure, and reduce the strain on the heart. They have been shown to significantly improve outcomes in heart failure patients by interrupting deleterious neurohormonal pathways2. In South America, the prevalence of ACEI/ARB use in CHD patients is 55.8%1.
Statins: Lipid-Lowering Agents
Statins are primarily used to lower cholesterol levels and reduce the risk of cardiovascular events. They inhibit the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Statins are widely prescribed for both primary and secondary prevention of cardiovascular diseases, with a prevalence of 78.9% in CHD patients in South America1. Additionally, statins have been investigated for their potential benefits in cancer therapeutics due to their pleiotropic properties4.
Antiplatelets and Aspirin: Preventing Blood Clots
Antiplatelet medications, including aspirin, are essential for preventing blood clots in patients with cardiovascular diseases. These medications inhibit platelet aggregation, reducing the risk of heart attacks and strokes. The use of antiplatelets and aspirin is highly prevalent among CHD patients, with rates of 84.6% and 85.1%, respectively, in South America1.
New Medications: Ivabradine and Sacubitril/Valsartan
Recent advancements in heart failure treatment have introduced new medications such as ivabradine and sacubitril/valsartan. Ivabradine works by targeting the If channels in the sinoatrial node, thereby decreasing heart rate. Sacubitril/valsartan combines a neprilysin inhibitor with an angiotensin receptor antagonist, offering improved clinical outcomes, including reduced hospitalizations and all-cause mortality2.
Drug-Related Cardiac Pathology: Risks and Considerations
While many medications are beneficial for heart health, some can have adverse effects. Non-steroidal anti-inflammatory drugs (NSAIDs), for example, are known to increase cardiovascular risk and are commonly used despite their potential hazards10. Additionally, certain anticancer agents, psychotropic medications, and other non-cardiac drugs can induce heart failure or exacerbate existing heart conditions3 6.
Conclusion
In summary, a variety of medications are used to manage heart conditions, each with its specific benefits and potential risks. Beta-blockers, ACE inhibitors, ARBs, statins, and antiplatelets are mainstays in cardiovascular therapy, while new medications like ivabradine and sacubitril/valsartan offer promising advancements. However, it is crucial to be aware of the potential cardiotoxic effects of certain drugs and to use them judiciously to optimize patient outcomes.
Sources and full results
Most relevant research papers on this topic
Prevalence of Cardioprotective Medication Use in Coronary Heart Disease Patients in South America: Systematic review and Meta-Analysis
Cardioprotective medication use in South America has increased, but could be further improved, particularly in community settings.
Meta-Analysis
Rigorous JournalNew medications for heart failure.
New-in-class medications ivabradine and sacubitril/valsartan show improved clinical outcomes in heart failure patients, reducing hospitalizations and all-cause mortality.
Literature ReviewDrug-related cardiac pathology
Drugs can cause potentially lethal cardiac changes and have synergistic effects, causing damage to cardiovascular tissues.
Common cardiovascular medications in cancer therapeutics.
Cardiac glycosides and statins show potential in preventing or improving the prognosis of common malignancies by reducing cardiovascular morbidity and mortality.
HYDROXYCHLOROQUINE (PLAQUENIL) CARDIOTOXICITY: AN UNCOMMON COMPLICATION OF A COMMON MEDICATION
Hydroxychloroquine (HCQ) can cause cardiotoxicity and lead to systolic or diastolic heart failure in patients with rheumatoid arthritis.
Case Report
Very Rigorous JournalHeart Failure Induced by Non-Cardiac Drugs
Non-cardiac drugs, such as anthracyclines and NSAIDs, can cause or worsen heart failure, highlighting the need for detailed drug exposure history in patients with heart failure symptoms.
Highly CitedBeneficial Extracardiac Effects of Cardiovascular Medications
Cardiovascular medications have diverse extra-cardiovascular effects, which can be beneficial in treating non-cardiovascular conditions.
Medications Used for the Cardiovascular System
Organic nitrates, calcium-channel blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and beta-adrenoceptor blocking drugs are commonly prescribed for treating and managing cardiovascular disorders.
Heart failure drug treatment
Heart failure drug treatment has progressed, but optimal implementation requires disease management programs to provide a multidisciplinary, holistic approach to optimal medical care.
Rigorous JournalHighly CitedUse of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries
Diclofenac, despite increasing cardiovascular risk, is included on essential medicine lists in 74 countries and is the most commonly used NSAID in 15 countries studied.
Rigorous JournalHighly Cited